Menopause misinformation is harming care, warn specialists

Many direct to client menopause companies are pointless and don’t enhance care, warn specialists in The BMJ.

They argue that the sharp rise in business companies for ladies looking for aid from menopausal signs raises considerations concerning the reliability and potential business bias of the data, and that signs are finest assessed by an intensive scientific historical past with remedy selections guided by scientific response and affected person preferences.

Some of the troubling developments arising from this surge is the promotion of routine hormone panel testing for the analysis of menopausal signs, they write. These exams can price a whole bunch of {dollars} and are marketed to sufferers and clinicians as vital for “individualizing” hormone remedy.

But in actuality, these exams are of restricted scientific use as a result of there isn’t any clearly outlined therapeutic window for menopausal hormone remedy, and a few testing methods don’t provide correct or exact evaluation of hormone ranges.

For perimenopause and menopause, hormone testing gives no dependable solution to decide who will profit from remedy, when the ultimate menstrual interval will happen, or whether or not it’s secure to discontinue contraception, they clarify.

Medical tips from the British Menopause Society, Nationwide Institute for Well being and Care Excellence, American Faculty of Obstetricians and Gynecologists and others agree: in girls over age 45 presenting with validated signs of menopause, together with menstrual irregularity, menopause is a scientific analysis, and hormone testing is pointless.

Regardless of this, many ladies now current with detailed hormone panels from wellness suppliers or on-line companies which can be usually used to justify taking custom-made hormone preparations or dietary supplements primarily based on marginal deviations from hormone thresholds that aren’t grounded in proof, write the authors.

Such custom-made hormone preparations (referred to as compounded hormone regimens) usually are not regulated in the identical manner as normal menopausal hormone remedy and haven’t been examined for effectiveness and security.

There’s additionally concern that inconsistencies within the portions of estrogen or progestogen in compounded hormone regimens may end up in irregular cell progress or most cancers within the womb (uterus) lining, they add.

Till we are able to set up individualized goal hormone ranges, there isn’t any function for business hormonal panel testing to information remedy, they argue. Within the meantime, such testing gives solely a false sense of precision.

They acknowledge that innovation is required however recommend that the normalization of hormone panel testing may very well be a symptom of a bigger downside: the commercialization of ladies’s well being and a motion away from evidence-based apply.

For midlife girls, efficient remedy begins not with numbers, however with listening, they conclude.